Albumin Level and Stroke. Potential Association Between Lower Albumin Level and Cardioembolic Aetiology

REFERENCES

• Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST, Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24, 35–41.
   PubMed Web of Science ®Google Scholar
• Bamford, J., Sandercock, P., Dennis, M., Burn, J., Warlow, C. (1991). Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet, 337, 1521– 1526.
   PubMed Web of Science ®Google Scholar
• Belayev, L., Liu, Y., Zhao, W., Busto, R., Ginsberg, M. D. (2001). Human albumin therapy of acute ischemic stroke. Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke, 32, 553–560.
   PubMed Web of Science ®Google Scholar
• Belayev, L., Busto, R., Zhao, W., Clemens, J. A., Ginsberg, M. D. (1997). Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats. Journal of Neurosurgery, 87, 595–601.
   PubMed Web of Science ®Google Scholar
• Belayev, L., Zhao, W., Pattany, P. M., Weaver, R. G., Huh, P. W., Lin, B., (1998). Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia. Stroke, 29, 2587–2599.
   PubMed Web of Science ®Google Scholar
• Danesh, J., Collins, R., Appleby, P., Peto, R. (1998). Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. Meta-analyses of prospective studies. The Journal of the American Medical Association, 279, 1477–1482.
   PubMed Web of Science ®Google Scholar
• Davalos, A., Ricart, W., Gonzalez-Huix, F., Soler, S., Marrugat, J., Molins, A., (1996). Effect of malnutrition after acute stroke on clinical outcome. Stroke, 27, 1028–1032.
   PubMed Web of Science ®Google Scholar
• del Zoppo, G. J., Levy, D. E., Wasiewski, W. W., Pancioli A. M., Demchuck A. M., Trammel J., (2009). Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke, 40, 1687–1691.
   PubMed Web of Science ®Google Scholar
• di Napoli, M., Papa, F., Bocola, V. (2001). Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke, 32, 133–138.
   PubMed Web of Science ®Google Scholar
• Dziedzic, T., Slowik, A.,& Szczudlik, A. (2004). Serum albumin level as a predictor of ischemic stroke outcome. Stroke, 35, e156–e158.
   PubMed Web of Science ®Google Scholar
• Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., Maseri, A. (1997). Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation, 96, 1180–1184.
   PubMed Web of Science ®Google Scholar
• Ginsberg, M. D., Hill, M. D., Palesch, Y. Y., Ryckborst, K. J., Tamariz, D. (2006). The ALIAS pilot trial. A dose-escalation and safety study of albumin therapy for acute ischemic stroke-I: Physiological responses and safety results. Stroke, 37, 2100–2106.
   PubMed Web of Science ®Google Scholar
• Goslinga, H., Eijzenbach, V., Heuvelmans, J. H., van der Laan de Vries, E., Melis, V. M., Schmid-Schönbein, H., (1992). Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke, 23, 181–188.
   PubMed Web of Science ®Google Scholar
• Grau, A. J., Weimar, C., Buggle, F., Heinrich, A., Goertler, M., Neumaier, S., (2001). On behalf of the German stroke data bank collaborators. Risk factors, outcome, and treatment in subtypes of ischemic stroke. The German Stroke Data Bank. Stroke, 32, 2559–2566.
   PubMed Web of Science ®Google Scholar
• Halliwell, B., Gutterridge, J. M. (1990). The antioxidants of human extracellular fluids. Archives of Biochemistry and Biophysics, 280, 1–8.
   PubMed Web of Science ®Google Scholar
• He, P., Curry, F. E. (1993). Albumin modulation of capillary permeability: role of endothelial cell [Ca]i. American Journal of Physiology, 265, H74–H82.
   PubMed Web of Science ®Google Scholar
• Heuschmann, P. U., Kolominsky-Rabas, P. L., Misselwitz, B., Hermanek, P., Leffmann, C., Janzen, R. W., (2004). For the German stroke registers study group. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke. Archives of Internal Medicine, 164, 1761–1768.
   PubMedGoogle Scholar
• Idicula, T. T., Waje-Andreassen, U., Brogger, J., Naess, H., Thomassen, L. (2009). Serum albumin in ischemic stroke patients: The higher the better. The Bergen stroke study. Cerebrovascular Diseases, 28, 13–17.
   PubMed Web of Science ®Google Scholar
• Imamura, T., Doi, Y., Arima, H. (2009). LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: The Hisayama study. Stroke, 40, 382–388.
   PubMed Web of Science ®Google Scholar
• Ladenvall, C., Jood, K., Blomstrand, C., Nilsson, S., Jern, C., Ladenvall, P. et.al. (2006). Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke, 37, 2018–2023.
   PubMed Web of Science ®Google Scholar
• Lyp, G. Y. H., Lowe, G. D. O., Rumley, A., Dunn, F. G. (1995). Increased markers of thrombogenesis in chronic atrial fibrillation: Effects of warfarin treatment. British Heart Journal, 73, 527–533.
   Google Scholar
• Montaner, J., Perea-Gainza, M., Delgado, P., Ribó, M., Chacón, P., Rosell, A., (2008). Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke, 39, 2280–2287.
   PubMed Web of Science ®Google Scholar
• Mukamal, K. J., Tolstrup, J. S., Friberg, J., Gronbaek, M., Jensen, G. (2006). Fibrinogen and albumin levels and risk of atrial fibrillation in men and women (the Copenhagen City Heart Study). The American Journal of Cardiology, 98, 75–81.
   PubMed Web of Science ®Google Scholar
• Nadal, A., Fuentes, E., Pastor, J., McNaughton, P. A. (1995). Plasma albumin is a potent trigger of calcium signals and DNA synthesis in astrocytes. Proceedings of the National Academy of Sciences, 92, 1426–1430.
   Google Scholar
• Palesch, Y. Y., Hill, M. D., Ryckborst, K. J., Tamariz, D., Ginsberg, M. D. (2006). The ALIAS pilot trial. A dose-escalation and safety study of albumin therapy for acute ischemic stroke-II: Neurologic outcome and efficacy analysis. Stroke, 37, 2107–2114.
   PubMed Web of Science ®Google Scholar
• Pittock, S. J., Meldrum, D., Hardiman, O., Thornton, J., Brennan, P., Moroney, J. T. (2003). The Oxfordshire community stroke project classification: Correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 12, 1–7.
   PubMedGoogle Scholar
• Quinlan, G. J., Martin, G. S., Evans, T. W. (2005). Albumin: Biochemical properties and therapeutic potential. Hepatology, 41, 1211–1219.
   PubMed Web of Science ®Google Scholar
• Tabernero, A., Medina, A., Sanchez-Abarca, L. I., Lavado, E., Medina, J. M. (1999). The effect of albumin on astrocyte energy metabolism is not brought about through the control of cytosolic Ca2+ concentrations but by free-fatty acid sequestration. Glia, 25, 1–9.
   Google Scholar
• Turaj, W., Słowik, A., Dziedzic, T., Pułyk, R., Adamski, M., Strojny, J., (2006). Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. Journal of the Neurological Sciences, 246, 13–19.
   PubMed Web of Science ®Google Scholar
• U.S. National Institute of Health [Online]. (n.d.). Retrieved January 27, 2010, from http://www.clinicaltrials.gov/ct2/show/NCT00235495?term=albumin±stroke&rank=1
   Google Scholar
• Zoellner, H., Hofler, M., Beckmann, R., Hufnagl, P., Vanyek, E., Bielek, E., (1996). Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. Journal of Cell Science, 109, 2571–2580.
   PubMed Web of Science ®Google Scholar